Citigroup’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
Other funds holding ARKG
Citigroup's ARKG Position: Q3 2026 in Review
Citigroup reduced its ARK Genomic Revolution ETF (ARKG) stake by 68% in Q3 2026, selling an estimated $66.7M and leaving 689,700 shares worth $37.4M. The position accounts for 0.01% of the portfolio, ranked #885.
Citigroup first reported a position in ARKG in Q1 2018 and has held it in 35 quarters since. The position peaked at $91.4M in Q2 2026. 316 funds tracked by Wall St. Rank hold ARKG as of Q3 2026.
- Citigroup held 689,700 shares of ARK Genomic Revolution ETF worth $37.4M as of Q3 2026.
- Citigroup sold 1,482,615 ARK Genomic Revolution ETF shares in Q3 2026, an estimated $66.7M.
- ARK Genomic Revolution ETF made up 0.01% of Citigroup's portfolio in Q3 2026, its #885 holding.
- Citigroup first reported a position in ARK Genomic Revolution ETF in Q1 2018 and has held it in 35 quarters since.
- Citigroup's ARK Genomic Revolution ETF position peaked at $91.4M in Q2 2026.
- 316 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q3 2026.
Based on Citigroup's 13F filing for Q3 2026, filed 4 Nov 2026.